InMode Ltd. (NASDAQ:INMD - Get Free Report)'s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $15.58 and last traded at $15.61, with a volume of 127922 shares traded. The stock had previously closed at $15.68.
Analysts Set New Price Targets
INMD has been the topic of a number of research analyst reports. Needham & Company LLC reissued a "hold" rating on shares of InMode in a report on Thursday, July 11th. Canaccord Genuity Group lowered their target price on shares of InMode from $21.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, July 12th. Jefferies Financial Group cut shares of InMode from a "buy" rating to a "hold" rating and cut their target price for the company from $21.00 to $19.00 in a research note on Tuesday, July 23rd. Finally, Barclays decreased their price target on shares of InMode from $33.00 to $29.00 and set an "overweight" rating on the stock in a research note on Monday, July 15th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $22.40.
Get Our Latest Report on InMode
InMode Price Performance
The company has a 50-day moving average of $17.35 and a 200 day moving average of $19.14. The company has a market cap of $1.34 billion, a PE ratio of 7.59 and a beta of 2.18.
InMode (NASDAQ:INMD - Get Free Report) last released its earnings results on Thursday, August 1st. The healthcare company reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.04). InMode had a return on equity of 20.83% and a net margin of 35.81%. The firm had revenue of $102.60 million during the quarter, compared to the consensus estimate of $104.81 million. During the same quarter last year, the business posted $0.65 EPS. InMode's revenue was down 24.6% compared to the same quarter last year. Equities research analysts expect that InMode Ltd. will post 1.35 EPS for the current year.
Institutional Trading of InMode
Several institutional investors and hedge funds have recently modified their holdings of the stock. Systematic Financial Management LP raised its position in InMode by 34.5% during the 2nd quarter. Systematic Financial Management LP now owns 866,619 shares of the healthcare company's stock valued at $15,807,000 after purchasing an additional 222,532 shares in the last quarter. Disciplined Growth Investors Inc. MN grew its holdings in InMode by 2.9% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 804,958 shares of the healthcare company's stock worth $14,682,000 after acquiring an additional 22,427 shares in the last quarter. Mackenzie Financial Corp increased its position in InMode by 24.3% during the 2nd quarter. Mackenzie Financial Corp now owns 108,200 shares of the healthcare company's stock valued at $1,974,000 after purchasing an additional 21,165 shares during the period. Doma Perpetual Capital Management LLC raised its holdings in shares of InMode by 70.0% in the 2nd quarter. Doma Perpetual Capital Management LLC now owns 2,011,240 shares of the healthcare company's stock valued at $36,685,000 after purchasing an additional 828,122 shares in the last quarter. Finally, Lombard Odier Asset Management Europe Ltd purchased a new stake in shares of InMode in the 2nd quarter worth approximately $4,104,000. Institutional investors own 68.04% of the company's stock.
About InMode
(
Get Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
See Also
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
